Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

This is an open-label, single arm, single center, non-randomized feasibility study of the Muse MRgFUS System in subjects with breast cancer. Subjects will undergo partial ablation of half (≤50%) of one of their tumors (if multifocal or multicentric disease) followed by surgical resection per standard of care. The partial tumor ablation design will ensure that no information is lost that would impact the subject's standard of clinical care. Because current care often includes testing on the tumor, retaining a portion of viable tumor is advised by the clinical team. To ensure viable tissue confi

Trial Details

NCT ID
NCT05291507
Phase
EARLY_PHASE1
Sponsor
University of Utah
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Muse MRgFUS System
Locations (sample)
  • Salt Lake City, Utah, United States|40.76078,-111.89105

Key Eligibility Criteria

  • Subject is able to speak and understand English.
  • Female subjects 18 years of age or older with invasive breast cancer undergoing surgery
  • ECOG \< 2.
  • ASA (American Society of Anesthesiologists) Physical Status Classification Scale assessment of I-II.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →